Verapamil can produce depression of left ventricular function, delayed atrioventricular conduction, and hypotension, which can be potentiated by hyperkalemia. We sought to investigate a direct cardiac interaction between verapamil and hyperkalemia. Studies utilized isolated guinea pig hearts (Langendorff) paced at 250 beats/min. Hearts were randomly assigned to perfusion (Krebs-Henseleit buffer) with potassium concentrations ([K]+) of 1.5, 3, 6 and 9 mmol/l. Infusion of verapamil at rates of 0.2 to 60 µg/min (approximately 3 × 10–8 to 10–5 mol/l) produced concentration-dependent reduction of isovolumic left ventricular developed pressure. As [K]+ increased, concentration response curves showed parallel shifts to the left. The ED50 for reduction of left ventricular developed pressure significantly decreased: 8.2 ± 3.7, 2.9 ± 1.4, 1.2 ± 0.7, 0.6 ± 0.2 µg/min (mean ± SD), respectively. Nifedipine and diltiazem were also studied in hearts perfused with 3 and 9 mmol/l [K]+. Infusion of nifedipine 0.003-1 µg/min (approximately 10–9 to 3 × 10–7 mol/l) produced concentration-dependent reduction of left ventricular developed pressure but the ED50 was not affected by [K]+: 0.06 ± 0.03 and 0.05 ± 0.04 µg/min, respectively. Nifedipine vehicle was without effect at the infusion rates tested. Infusion of diltiazem 2–200 µg/min (approximately 3 × 10–7 to 3 × 10–5 mol/l) also produced concentration-dependent reduction of left ventricular developed pressure. The ED50 for diltiazem-induced reduction of left ventricular developed pressure was significantly reduced by elevated [K]+: 20.1 ± 6.7 and 3.5 ± 0.9 µg/min with 3 and 9 mmol/l [K]\ respectively. Conclusion, verapamil-induced reduction of left ventricular developed pressure was significantly influenced by buffer potassium concentration, showing a direct interaction between hyperkalemia and verapamil on the heart. A similar interaction was observed with diltiazem but not nifedipine, suggesting that the interaction was not general for all calcium entry blockers.